ProjektkooperationAktualisiert am 19. Februar 2025
Next generation drug screening for precision oncology
Details
CBmed is developing an innovative quality-assured workflow to test the effect of drugs on patient-derived tumor cell with a particular interest on ovarian cancer and glioblastoma. This method can furnish a personalized medicine approach as the individual patient response to drugs can be established. Furthermore, combining these readouts with other -omics data can provide unprecedented access to precision oncology.
We are currently interested in identifying partners (especially from industry and ELSA) who would be interested in developing this project with us for submission to a 2023 2-stage call (HORIZON-HLTH-2024-TOOL-05-06-twostage: Innovative non-animal human-based tools and strategies for biomedical research)
Phase
- Early - project idea
- Planning
Typ
- Citizen engagement
- National, regional, local authority
- Basic research
- Applied research
- Other
- Standardisation
- Policy
- Producer, Manfacturer, Software Developer
Ähnliche Einträge
Expertise
Next generation drug screening for precision oncology
- Health
Leen Assil Companioni
Public Funding Specialist bei CBmed GmbH
Graz, Österreich
Projektkooperation
- Basic research
- Applied research
- Producer, Manfacturer, Software Developer
- Testing: customer, end-user, user, client, patient etc.
Deepak v Katkoria
Proj. Manager bei logiicdev GmbH
Graz, Australien
Projektkooperation
CraftWerk Obervellach – Innovation Hub for Sustainable Craftsmanship and Regional Development
- Execution
- Basic research
- Applied research
- Citizen engagement
- National, regional, local authority
Lukas Patschg
LIN Koordinator bei Kollektiv Zukunft - Regionale Entwicklung Mölltal
Obervellach, Österreich